Briviact is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Brand Manufacturer: UCB
Reviews
Write a review
The product has no reviews
Leave your review
